Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.

1988 • 565 citations

Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their Tumors

1992 • 551 citations

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.

1990 • 414 citations

Myeloma Proteins as Tumor-Specific Transplantation Antigens

1972 • 325 citations

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

1986 • 318 citations

Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells.

1987 • 299 citations

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

1991 • 279 citations

Subunit promiscuity among hemopoietic growth factor receptors

1991 • 273 citations

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

1991 • 245 citations

Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.

1988 • 227 citations

Characterization of a carcinogen‐induced murine B lymphocyte cell line of C3H/eB origin

1977 • 169 citations

Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.

1987 • 168 citations

GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells

1992 • 142 citations

Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.

1991 • 140 citations

Idiotypic vaccination as a treatment for a B cell lymphoma.

1988 • 123 citations

Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.

1987 • 118 citations

Monoclonal Anti-Idiotype Antibodies Against the Murine B Cell Lymphoma 38C13: Characterization and Use as Probes for the Biology of the Tumor In Vivo and In Vitro

1985 • 115 citations

Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms.

1985 • 104 citations

Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide.

1988 • 95 citations

Purification and characterization of a human T-lymphocyte-derived granulocyte-macrophage colony-stimulating factor

1981 • 87 citations

[32] Production and properties of chimeric antibody molecules

1989 • 85 citations

Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function.

1990 • 75 citations

PROTECTIVE AND CELLULAR IMMUNE RESPONSES TO IDIOTYPIC DETERMINANTS ON CELLS FROM A SPONTANEOUS LYMPHOMA OF NZB/NZW F1 MICE

1974 • 75 citations

Tumor Immunity Induced by Preimmunization With BALB/c Mouse Myeloma Protein2

1976 • 45 citations

Alternative V kappa gene rearrangements in a murine B cell lymphoma. An explantation for idiotypic heterogeneity.

1988 • 29 citations

Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.

1988 • 24 citations

A novel strategy for converting recombinant viral protein into high immunogenic antigen

1991 • 17 citations

Cited By (0)

Loading...